The technology underpinning the Bio-Stream pathogen detection platform is unique at multiple levels.
- Proprietary synthetic antibodies for whole virus detection
- Virtually instantaneous results with fast antibody binding
- High accuracy
- Low cost consumables
- Powered by Artificial Intelligence
- Architected on APIs allowing seamless integration
- Data is captured on a trusted data platform
- Affordable monthly pricing models
Bio-Stream has a solution.
On-site, proactive screening for pathogens such as the SARS-CoV-2 virus is only feasible when testing can be done in a way that makes it easy to incorporate into the corporate health and safety culture – with minimum disruption to the workflows.
Bio-Stream screening tests stand alone against current market leaders because of their accuracy, speed and low cost per test. They offer high sensitivity and specificity, but deliver results faster than other tests of that caliber on the market today.
Test results are instantly shared with the person through our digital health passport in the form of a scannable time-stamped verification of their Covid-free status – allowing them to move around confidently between tests.
Bio-Stream screening tests are being developed specifically for corporate enterprises and other organizations that need to routinely screen large numbers of people for the purposes of maintaining workplace health and safety.